Not Rated
| 
						Fund Size
						  (0.01% of Investment in Category) 
					 | 
					
						Expense Ratio
						  (0.28% Category average) 
					 | 
				
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category | 
|---|---|---|---|---|---|---|
| 1 Week | 27-Oct-25 | 10039.00 | 0.39% | - | 0.41% | 187/738 | 
| 1 Month | 03-Oct-25 | 10346.00 | 3.46% | - | 3.16% | 280/730 | 
| 3 Month | 01-Aug-25 | 10172.80 | 1.73% | - | 6.27% | 504/711 | 
| 6 Month | 02-May-25 | 10746.10 | 7.46% | - | 9.85% | 314/669 | 
| YTD | 01-Jan-25 | 9937.80 | -0.62% | - | 9.87% | 515/616 | 
| 1 Year | 31-Oct-24 | 10285.60 | 2.86% | 2.83% | 8.84% | 445/587 | 
| Since Inception | 09-Sep-24 | 10414.90 | 4.15% | 3.60% | 12.05% | 664/760 | 
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns | 
|---|---|---|---|---|---|
| 1 Year | 31-Oct-24 | 12000 | 12580.25 | 4.84 % | 9.02 % | 
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty | 
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 22.7 | 12.81% | 0.02% | 15.66% (Apr 2025) | 12.79% (Aug 2025) | 14.25 k | -0.43 k | 
| Cipla Ltd. | Pharmaceuticals | 11.3 | 6.37% | -0.46% | 7.01% (Feb 2025) | 6.37% (Sep 2025) | 7.52 k | -0.34 k | 
| Max Healthcare Institute Ltd. | Hospital | 11.1 | 6.27% | -0.21% | 7.1% (Jun 2025) | 5.62% (Nov 2024) | 9.97 k | -0.30 k | 
| Apollo Hospitals Enterprises Ltd. | Hospital | 10.1 | 5.67% | -0.15% | 5.82% (Aug 2025) | 5.35% (Nov 2024) | 1.36 k | -41.00 | 
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 10.1 | 5.67% | -0.18% | 6.35% (Dec 2024) | 5.62% (Mar 2025) | 8.22 k | -0.25 k | 
| Divis Laboratories Ltd. | Pharmaceuticals | 9.8 | 5.52% | -0.40% | 6.62% (May 2025) | 5.52% (Sep 2025) | 1.72 k | -51.00 | 
| Fortis Healthcare Ltd. | Hospital | 6.8 | 3.84% | 0.23% | 3.84% (Sep 2025) | 2.52% (Oct 2024) | 7.03 k | -0.21 k | 
| Lupin Ltd. | Pharmaceuticals | 6.2 | 3.52% | 0.04% | 4.27% (Dec 2024) | 3.47% (Jul 2025) | 3.27 k | -97.00 | 
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.1 | 2.87% | 0.03% | 2.92% (Jul 2025) | 2.26% (Oct 2024) | 1.42 k | -42.00 | 
| Laurus Labs Ltd. | Pharmaceuticals | 4.4 | 2.49% | -0.04% | 2.53% (Aug 2025) | 1.5% (Oct 2024) | 5.25 k | -0.15 k | 
| Name | Type of Instrument | Weight (%) | 
|---|---|---|
| TREPS | TREPS | 0.33% | 
| Margin | Margin | 0.00% | 
| Net Receivables | Net Receivables | -0.40% | 
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name  | 
                Crisil Rank  | 
                Asset Size (Cr)  | 
                1M  | 
                3M  | 
                6M  | 
                1Y  | 
                3Y  | 
              
|---|---|---|---|---|---|---|---|
| Mirae Asset NYSE FANG+ ETF - Regular Plan - Growth | NA | 3491.94 | 4.87 | 15.85 | 39.15 | 52.98 | 63.04 | 
| Tata Silver Exchange Traded Fund | NA | 709.61 | 4.09 | 35.63 | 56.39 | 52.11 | 0.00 | 
| ICICI Prudential Silver ETF | NA | 9481.23 | 2.41 | 35.00 | 56.20 | 51.58 | 36.28 | 
| Aditya Birla Sun Life Silver ETF | NA | 1580.22 | 2.39 | 34.93 | 56.14 | 51.56 | 36.32 | 
| DSP Silver ETF | NA | 1449.76 | 2.51 | 35.03 | 56.20 | 51.55 | 36.08 | 
| Mirae Asset Silver ETF | NA | 376.62 | 2.43 | 34.95 | 56.10 | 51.51 | 0.00 | 
| Axis Silver ETF | NA | 638.38 | 2.39 | 34.86 | 56.02 | 51.45 | 36.15 | 
| HDFC Silver ETF | NA | 2425.57 | 2.46 | 34.97 | 56.10 | 51.44 | 36.14 | 
| Kotak Silver ETF | NA | 2018.23 | 2.40 | 34.90 | 56.00 | 51.39 | 0.00 | 
| SBI Silver ETF | NA | 1982.35 | 2.40 | 34.85 | 55.91 | 51.31 | 0.00 | 
Out of 71 mutual fund schemes offered by this AMC, 7 is/are ranked 5 * , 5 is/are ranked 4 * , 7 is/are ranked 3 * , 6 is/are ranked 2 * , 1 is/are ranked 1 * , and 45 schemes are not ranked. See more about AMC
| Scheme Name  | 
		Crisil Rank  | 
		Asset Size (Cr)  | 
		1M  | 
		3M  | 
		6M  | 
		1Y  | 
		3Y  | 
	  
|---|---|---|---|---|---|---|---|
| Bandhan Corporate Bond Fund - Direct Plan - Growth | 5 | 15902.88 | 0.70 | 1.18 | 3.05 | 8.18 | 7.79 | 
| Bandhan Small Cap Fund - Direct Plan - Growth | 5 | 15737.73 | 4.50 | 3.00 | 16.07 | 4.30 | 32.74 | 
| Bandhan Liquid Fund - Direct Plan - Growth | 4 | 13140.66 | 0.49 | 1.44 | 3.02 | 6.74 | 7.07 | 
| Bandhan Banking and PSU Fund - Direct Plan - Growth | 5 | 13081.90 | 0.66 | 1.27 | 3.02 | 7.89 | 7.61 | 
| Bandhan Money Market Fund - Direct Plan - Growth | 1 | 12246.66 | 0.52 | 1.49 | 3.45 | 7.76 | 7.66 | 
| Bandhan Large & Mid Cap Fund - Direct Plan - Growth | 5 | 10817.90 | 4.44 | 5.10 | 11.73 | 8.63 | 24.96 | 
| Bandhan Bond Fund - Short Term - Direct Plan - Growth | 5 | 10673.19 | 0.69 | 1.09 | 3.16 | 8.43 | 8.16 | 
| Bandhan Value Fund - Direct Plan - Growth | 2 | 9942.10 | 3.77 | 3.63 | 6.10 | 2.40 | 18.67 | 
| Bandhan Arbitrage Fund - Direct Plan - Growth | 4 | 8560.65 | 0.55 | 1.38 | 2.98 | 7.09 | 7.73 | 
| Bandhan Flexi Cap Fund - Direct Plan - Growth | 3 | 7383.72 | 3.79 | 3.16 | 7.84 | 6.99 | 16.02 |